News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
104,402 Results
Type
Article (6614)
Company Profile (22)
Press Release (97766)
Multimedia
Podcasts (2)
Webinars (2)
Section
Business (31401)
Career Advice (200)
Deals (4873)
Drug Delivery (5)
Drug Development (9117)
Employer Resources (13)
FDA (2911)
Job Trends (2994)
News (50598)
Policy (5511)
Tag
Academia (673)
Academic (1)
Allergies (19)
Alliances (10027)
ALS (8)
Alzheimer's disease (192)
Antibody-drug conjugate (ADC) (18)
Approvals (2955)
Artificial intelligence (37)
Automation (9)
Bankruptcy (29)
Best Places to Work (2325)
BIOSECURE Act (1)
Biosimilars (5)
Biotechnology (16)
Bladder cancer (11)
Brain cancer (4)
Breast cancer (52)
Cancer (375)
Cardiovascular disease (23)
Career advice (184)
Career pathing (1)
CAR-T (21)
Cell therapy (50)
Cervical cancer (9)
Clinical research (7071)
Collaboration (159)
Compensation (2)
Complete response letters (3)
COVID-19 (554)
CRISPR (6)
C-suite (22)
Cystic fibrosis (9)
Data (306)
Depression (1)
Diabetes (24)
Diagnostics (3169)
Digital health (1)
Diversity, equity & inclusion (3)
Drug discovery (20)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (8)
Earnings (9075)
Employer branding (3)
Employer resources (11)
Events (10502)
Executive appointments (112)
FDA (3067)
Frontotemporal dementia (1)
Funding (91)
Gene editing (9)
Generative AI (3)
Gene therapy (37)
GLP-1 (103)
Government (904)
Grass and pollen (3)
Guidances (6)
Healthcare (2309)
Immunology and inflammation (3)
Indications (4)
Infectious disease (583)
Inflammatory bowel disease (7)
Influenza (12)
Intellectual property (13)
Interviews (24)
IPO (1464)
Job creations (784)
Job search strategy (175)
Kidney cancer (1)
Labor market (3)
Layoffs (32)
Leadership (1)
Legal (1141)
Liver cancer (9)
Lung cancer (64)
Lymphoma (26)
Machine learning (2)
Management (3)
Manufacturing (54)
MASH (4)
Medical device (1380)
Medtech (1380)
Mergers & acquisitions (3488)
Metabolic disorders (51)
Multiple sclerosis (4)
NASH (1)
Neurodegenerative disease (12)
Neuropsychiatric disorders (1)
Neuroscience (232)
NextGen: Class of 2025 (839)
Non-profit (588)
Now hiring (11)
Obesity (23)
Opinion (14)
Ovarian cancer (5)
Pain (7)
Pancreatic cancer (8)
Parkinson's disease (14)
Partnered (4)
Patents (20)
Patient recruitment (6)
Peanut (14)
People (9600)
Pharmaceutical (6)
Phase I (2075)
Phase II (2733)
Phase III (2743)
Pipeline (151)
Policy (5)
Postmarket research (399)
Preclinical (1221)
Press Release (18)
Prostate cancer (23)
Psychedelics (2)
Radiopharmaceuticals (29)
Rare diseases (33)
Real estate (1971)
Recruiting (4)
Regulatory (3779)
Reports (7)
Research institute (636)
Resumes & cover letters (19)
RSV (4)
Series A (14)
Series B (8)
Sickle cell disease (5)
Spinal muscular atrophy (34)
Sponsored (6)
Startups (630)
State (1)
Stomach cancer (2)
Supply chain (10)
Tariffs (2)
The Weekly (2)
Vaccines (52)
Venture capitalists (1)
Weight loss (12)
Women's health (3)
Date
Today (17)
Last 7 days (80)
Last 30 days (289)
Last 365 days (3990)
2025 (1205)
2024 (4473)
2023 (5345)
2022 (8667)
2021 (9076)
2020 (8900)
2019 (6275)
2018 (4849)
2017 (5236)
2016 (5350)
2015 (5956)
2014 (4803)
2013 (4246)
2012 (4496)
2011 (4552)
2010 (4042)
Location
Africa (125)
Alabama (10)
Alaska (1)
Arizona (34)
Arkansas (2)
Asia (6376)
Australia (1076)
California (657)
Canada (252)
China (30)
Colorado (37)
Connecticut (31)
Delaware (27)
Europe (14192)
Florida (91)
Georgia (10)
Idaho (5)
Illinois (41)
India (3)
Indiana (37)
Iowa (2)
Japan (20)
Kansas (21)
Kentucky (4)
Louisiana (1)
Maine (24)
Maryland (107)
Massachusetts (440)
Michigan (59)
Minnesota (34)
Missouri (35)
Montana (9)
Nebraska (3)
Nevada (3)
New Hampshire (7)
New Jersey (287)
New Mexico (8)
New York (217)
North Carolina (148)
North Dakota (1)
Northern California (255)
Ohio (39)
Oklahoma (3)
Oregon (3)
Pennsylvania (116)
Rhode Island (10)
South America (176)
South Carolina (4)
Southern California (266)
Tennessee (17)
Texas (169)
United States (2806)
Utah (43)
Virginia (13)
Washington D.C. (4)
Washington State (83)
Wisconsin (10)
104,402 Results for "omega laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Novo Partner Omega Waves Bankruptcy Flag from Sinking Ship
Just over a year after striking an obesity deal with Novo Nordisk, an SEC filing shows Flagship Pioneering spinout Omega Therapeutics is days away from bankruptcy and will lay off up to 17 employees.
February 4, 2025
·
1 min read
·
Kate Goodwin
BioMidwest
Omega Laboratories Achieves SAMHSA Accreditation
Omega Laboratories, Inc. announces that its state-of-the-art laboratory in Ontario, Canada has received Substance Abuse and Mental Health Services Administration accreditation from the National Laboratory Certification Program.
October 17, 2023
·
3 min read
Business
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
Omega Therapeutics, Inc. today announced the election of Richard N. Kender to its Board of Directors following its annual meeting of stockholders.
June 24, 2024
·
6 min read
Press Releases
Intrommune Therapeutics Announces Publication of OMEGA Study in Peanut Allergic Adults in Annals of Allergy, Asthma & Immunology
February 19, 2025
·
4 min read
Genetown
Omega Therapeutics To Participate In Two Upcoming Investor Conferences - May 30, 2024
Omega Therapeutics, Inc. today announced that management will participate in fireside chats at two upcoming investor conferences.
May 30, 2024
·
1 min read
BioMidwest
Omega Laboratories Achieves ISO 17025 Accreditation at Ontario, Canada Laboratory
Omega Laboratories, a leading provider of laboratory testing solutions, is proud to announce that its toxicology laboratory in Ontario, Canada, has been awarded ISO 17025 accreditation.
May 31, 2023
·
2 min read
Business
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
Omega Therapeutics, Inc., a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, announced the appointment of Kaan Certel, Ph.D., as Chief Business Officer.
May 29, 2024
·
6 min read
Business
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
Omega Therapeutics, Inc. announced financial results for the first quarter ended March 31, 2024, and highlighted recent Company progress.
May 6, 2024
·
10 min read
Deals
Juno Pharmaceuticals Acquires Omega Laboratories, Propelling Canada’s Pharmaceutical Industry Forward
Today, Juno Pharmaceuticals Canada announced the acquisition of Omega Laboratories (“Omega”), one of Canada’s largest domestic specialty injectable pharmaceutical manufacturers.
May 15, 2023
·
3 min read
Business
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”) today announced financial results for the fourth quarter and full year ended December 31, 2023, and a strategic prioritization initiative to focus resources on near-term milestones to support long-term shareholder value.
March 28, 2024
·
14 min read
1 of 10,441
Next
